Moreover, the combined expression of miR-124 and MEG3 emerged as an independent prognostic factor in RCC, where the overexpression of miR-124 or MEG3 inhibited cell proliferation, migration, and invasion, and restrained tumor growth. This evidence concerns the gene MEG3 and renal cell carcinoma.